Xiaoli Xu

1.3k total citations
37 papers, 912 citations indexed

About

Xiaoli Xu is a scholar working on Oncology, Pathology and Forensic Medicine and Cancer Research. According to data from OpenAlex, Xiaoli Xu has authored 37 papers receiving a total of 912 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 12 papers in Pathology and Forensic Medicine and 9 papers in Cancer Research. Recurrent topics in Xiaoli Xu's work include Breast Lesions and Carcinomas (8 papers), Breast Cancer Treatment Studies (8 papers) and HER2/EGFR in Cancer Research (6 papers). Xiaoli Xu is often cited by papers focused on Breast Lesions and Carcinomas (8 papers), Breast Cancer Treatment Studies (8 papers) and HER2/EGFR in Cancer Research (6 papers). Xiaoli Xu collaborates with scholars based in China and United States. Xiaoli Xu's co-authors include Zachary M. Weil, Laura K. Fonken, Randy J. Nelson, Sanjay Rajagopalan, Qinghua Sun, Wentao Yang, Baohua Yu, Rui Bi, Hongfen Lu and Yufan Cheng and has published in prestigious journals such as Molecular Psychiatry, Cardiovascular Research and The American Journal of Surgical Pathology.

In The Last Decade

Xiaoli Xu

34 papers receiving 896 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoli Xu China 13 334 206 153 126 125 37 912
Francesco Barretta Italy 17 269 0.8× 143 0.7× 91 0.6× 23 0.2× 178 1.4× 62 1.1k
Chiara Milani Italy 13 306 0.9× 166 0.8× 100 0.7× 32 0.3× 108 0.9× 30 1.3k
Chan‐Na Zhao China 16 223 0.7× 72 0.3× 78 0.5× 33 0.3× 55 0.4× 40 867
Yan‐Mei Mao China 17 187 0.6× 94 0.5× 80 0.5× 32 0.3× 47 0.4× 39 880
Nick Woodward United Kingdom 11 255 0.8× 113 0.5× 64 0.4× 106 0.8× 126 1.0× 12 1.2k
Ziqiang Lin China 20 376 1.1× 82 0.4× 72 0.5× 80 0.6× 79 0.6× 91 1.1k
Yifeng Yang China 15 160 0.5× 110 0.5× 101 0.7× 19 0.2× 159 1.3× 46 788
Martin Lehnert Germany 21 383 1.1× 102 0.5× 124 0.8× 13 0.1× 313 2.5× 78 1.2k
Christopher F. Rider Canada 23 371 1.1× 124 0.6× 158 1.0× 46 0.4× 284 2.3× 42 1.4k
Katherine D. Henderson United States 19 279 0.8× 476 2.3× 152 1.0× 26 0.2× 64 0.5× 24 1.1k

Countries citing papers authored by Xiaoli Xu

Since Specialization
Citations

This map shows the geographic impact of Xiaoli Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoli Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoli Xu more than expected).

Fields of papers citing papers by Xiaoli Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoli Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoli Xu. The network helps show where Xiaoli Xu may publish in the future.

Co-authorship network of co-authors of Xiaoli Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoli Xu. A scholar is included among the top collaborators of Xiaoli Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoli Xu. Xiaoli Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Qiang, Baohua Yu, Rui Bi, et al.. (2025). Carcinoma arising in microglandular adenosis of the breast: clinicopathological and genetic analysis. Journal of Clinical Pathology. 79(1). 31–36.
2.
Li, Hong, Xiaoli Xu, & Tong Yan. (2025). Serum YKL-40 Levels as a Non-Invasive Potential Biomarker for Liver Fibrosis Patients: A Systematic Review and Meta-Analysis. Iranian Journal of Public Health. 54(5). 939–950. 1 indexed citations
3.
Yuan, Lili, Xiaoli Xu, Yi‐Wen Huang, et al.. (2024). Exploring epigenetic dynamics unveils a super-enhancer-mediated NDRG1-β-catenin axis in modulating gemcitabine resistance in pancreatic cancer. Cancer Letters. 605. 217284–217284. 5 indexed citations
4.
Bai, Qianming, Ming Li, Shuling Zhou, et al.. (2024). Response to anti-HER2 neoadjuvant chemotherapy in HER2-positive invasive breast cancers with different HER2 FISH patterns. Journal of Clinical Pathology. 78(8). 540–547. 3 indexed citations
5.
Li, Ming, et al.. (2023). HER2-low breast cancer: evolution of HER2 expression from primary tumor to distant metastases. BMC Cancer. 23(1). 656–656. 10 indexed citations
6.
Xu, Xiaoli, et al.. (2022). Risk factors of herpes simplex virus reactivation after surgery for primary trigeminal neuralgia. Journal of NeuroVirology. 28(3). 367–373. 2 indexed citations
7.
Xu, Xiaoli, Rui Bi, Ruohong Shui, et al.. (2021). Clinicopathological significance of WT1 expression in invasive breast carcinoma with >90% mucinous component. Journal of Clinical Pathology. 75(12). 832–836. 2 indexed citations
8.
Zhou, Shuling, Anqi Li, Hong Lv, et al.. (2021). High frequency ofPIK3CAandTERTpromoter mutations in fibromatosis-like spindle cell carcinomas. Journal of Clinical Pathology. 75(7). 477–482. 6 indexed citations
9.
Xu, Xiaoli, et al.. (2018). [Angiofibroma of soft tissue: a clinicopathologic analysis of 24 cases].. PubMed. 47(8). 616–621. 2 indexed citations
10.
Bai, Qi, et al.. (2018). [Mammary myofibroblastoma: a clinicopathologic analysis of nine cases].. PubMed. 47(10). 747–752. 1 indexed citations
11.
Xu, Xiaoli, Rui Bi, Ruohong Shui, et al.. (2018). Micropapillary pattern in pure mucinous carcinoma of the breast – does it matter or not?. Histopathology. 74(2). 248–255. 15 indexed citations
12.
Ruan, Miao, Tian Tian, Xiaoli Xu, et al.. (2018). Predictive value of tumor-infiltrating lymphocytes to pathological complete response in neoadjuvant treated triple-negative breast cancers. Diagnostic Pathology. 13(1). 66–66. 36 indexed citations
13.
Bi, Rui, Lei Shen, Xiongzeng Zhu, & Xiaoli Xu. (2015). Malignant ameloblastoma (metastatic ameloblastoma) in the lung: 3 cases of misdiagnosis as primary lung tumor with a unique growth pattern. Diagnostic Pathology. 10(1). 123–123. 13 indexed citations
14.
Sun, Lei, Jun Lü, Xiao‐Jiang Yu, et al.. (2011). Adenine Sulfate Improves Cardiac Function and the Cardiac Cholinergic System After Myocardial Infarction in Rats. Journal of Pharmacological Sciences. 115(2). 205–213. 11 indexed citations
15.
Fonken, Laura K., Xiaoli Xu, Zachary M. Weil, et al.. (2011). Air pollution impairs cognition, provokes depressive-like behaviors and alters hippocampal cytokine expression and morphology. Molecular Psychiatry. 16(10). 987–995. 378 indexed citations
16.
Liu, Xiaowen, Yufan Cheng, Weiqi Sheng, et al.. (2010). Analysis of Clinicopathologic Features and Prognostic Factors in Hepatoid Adenocarcinoma of the Stomach. The American Journal of Surgical Pathology. 34(10). 1465–1471. 71 indexed citations
17.
Xu, Xiaoli, et al.. (2009). A study on exercise interventions for postoperative breast cancer patients with fatigue. 23(29). 2655–2656. 1 indexed citations
18.
Yang, Jianjun, Xiaoli Xu, Jin-Chun Shen, Weiyan Li, & Zhiqiang Zhou. (2009). No Decrease in Central Venous Pressure when Epinephrine-Induced Hypotension Occurs. Journal of Pharmacy & Pharmaceutical Sciences. 12(1). 86–86. 1 indexed citations
19.
Xu, Xiaoli, et al.. (2008). Exercise training combined with angiotensin II receptor blockade limits post-infarct ventricular remodelling in rats. Cardiovascular Research. 78(3). 523–532. 53 indexed citations
20.
Xu, Xiaoli. (2006). The microsurgical management of patients with recurrent trigeminal neuralgia after microvascular decompression. Zhonghua shenjing waike zazhi. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francesco Barretta Breakdown of academic impact, for papers by Chiara Milani Breakdown of academic impact, for papers by Chan‐Na Zhao Breakdown of academic impact, for papers by Yan‐Mei Mao Breakdown of academic impact, for papers by Nick Woodward Breakdown of academic impact, for papers by Ziqiang Lin Breakdown of academic impact, for papers by Yifeng Yang Breakdown of academic impact, for papers by Martin Lehnert Breakdown of academic impact, for papers by Christopher F. Rider Breakdown of academic impact, for papers by Katherine D. Henderson
Rankless by CCL
2026